R. Phillips

A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9

J. Brown, B. Naylor, G. Flannigan, 2001, British Journal of Cancer.

Oxygen-bridged Dinuclear Ruthenium Amine Complex Specifically Inhibits Ca2+ Uptake into Mitochondria in Vitroand in Situ in Single Cardiac Myocytes*

D. Bers, S. Ahmed, K. Choi, 1998, The Journal of Biological Chemistry.

The relative importance of NADPH: cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions.

A. Harris, A. Patterson, I. Stratford, 2000, Biochemical pharmacology.

A novel strategy for NQO 1 ( NAD ( P ) H : quinone oxidoreductase , EC 1 . 6 . 99 . 2 ) mediated therapy of bladder cancer based on the pharmacological properties of EO 9

B. Naylor, G. Flannigan, G. Choudry, 2022 .

5-substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4,7-dione]prop-2-en- 1-ol (EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitro.

G. Adams, I. Stratford, M. Jaffar, 1998, Anti-cancer drug design.